The Form 4 filing, an SEC report of insider stock trades, was filed on November 16, 2026. It covers sales made on November 12, 2026, by Jeffrey Finer, chief executive officer of Septerna (SEPN).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-12 |
| Date of Latest Transaction | 2026-11-12 |
| Buy/Sell | sell |
| Transaction Count | 5 |
| Shares Transacted | 18,500 |
| Price | $43.62 |
| Total Transaction Value | $807,014.69 |
| Insider | |
| Ticker Symbol | SEPN |
| Company | Septerna, Inc. |
| Insider Name | Finer Jeffrey |
| Insider Title | Chief Executive Officer |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 833,909 |
| Position Size Change | 2.17% |
| Filing | |
| Filing Date | 2026-11-16 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales reported with transaction code S. The five transactions involved 18,500 shares of Septerna stock.
What was the average price of the transaction?
The average sale price was $43.62 per share, rounded to cents. This average covers all five transactions; prices for each separate sale were not provided.
How did this transaction affect the insider's holdings?
Jeffrey Finer sold 18,500 shares and reported 833,909 shares owned afterward. The shares sold made up 2.17% of his reported holdings before the sales.
What's the total transaction value?
The five sales totaled $807,014.69. Before rounding to cents, the total was $807,014.686.
Are there any special circumstances around this transaction?
The filing information includes a reference to a Rule 10b5-1 trading plan. These plans set trading instructions in advance. The available details do not show which of the five sales the reference covers. Footnote text and plan terms were not provided, so the plan's scope remains unclear.
For research purposes only; not investment advice.